COPD Trial, Recruiting NCT04801108 Sponsor: Beth Israel Deaconess Medical Center Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT04801108
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 40 and 75 years of age.
  • People whose condition is stable and who are taking less than 10mg of prednisone (or a similar steroid medication) per day.
  • People who have not smoked for at least 4 months before the screening visit and who are willing to remain non-smoking for the entire study period.
  • People who completed a supervised lung rehabilitation program within the past 12 months, or who are regularly continuing maintenance lung rehabilitation if their original program was completed more than 12 months ago.
  • People who have a current, up-to-date pneumococcal vaccination.
  • People who have a current, up-to-date influenza (flu) vaccination.
  • People who are willing and able to attend all required follow-up visits and complete all study procedures.

Who may not be able to join:

  • People whose lung scan results show a specific structural lung characteristic (very high fissure completion on a chest CT scan), or whose airflow test shows no collateral ventilation (confirm with trial site).
  • People who produce more than about 4 tablespoons of mucus per day.
  • People who have had a heart attack within the 6 months before screening.
  • People with uncontrolled heart failure.
  • People who have had three or more episodes of pneumonia in the past year.
  • People who have had three or more severe COPD flare-ups in the past year.
  • People who have previously had a lung transplant, lung volume reduction surgery, or surgical removal of part or all of a lung.
  • People with a significant lung condition involving abnormally widened airways (bronchiectasis).
  • People who cannot safely stop taking blood thinners or anti-clotting medications for 7 days.
  • People with uncontrolled high blood pressure in the lungs, or a history of a related heart condition called Cor Pulmonale, based on a heart ultrasound done within the past 3 months.
  • People whose heart pumping function is below a certain level (less than 40%), based on a heart ultrasound done within the past 3 months.
  • People with a resting heart rate that is too slow, or with certain types of irregular heartbeats (confirm with trial site for specific heart rhythm details).
  • People whose lung airflow measurement (after using a bronchodilator) falls outside a specific range — either too low or too high — compared to what is expected for someone their age and size.
  • People whose total lung capacity is below what would normally be expected for someone their age and size, as measured by a breathing test.
  • People whose lung air trapping levels fall below certain thresholds, depending on their type of emphysema, as measured by a breathing test.
  • People whose lungs' ability to transfer oxygen into the blood is below 20% of the expected level.
  • People whose walking distance in a 6-minute walk test (done after rehabilitation) is either less than 100 metres or more than 450 metres.
  • People with too much carbon dioxide in their blood while breathing normal room air.
  • People with too little oxygen in their blood while breathing normal room air.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2021
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Prove that inter-lobar fissures can be completed to at least 95% via robotic thoracic surgery or VATS in severe emphysema patients; Prove that patients consented for the procedure will ultimately undergo the intervention; Incidence of severe adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov